Last reviewed · How we verify

Bioactive glass

King Abdulaziz University · Phase 3 active Small molecule

Bioactive glass promotes bone regeneration and healing by releasing bioactive ions that stimulate osteoblast activity and mineralization at the implant site.

Bioactive glass promotes bone regeneration and healing by releasing bioactive ions that stimulate osteoblast activity and mineralization at the implant site. Used for Bone defect repair and regeneration, Dental and maxillofacial applications.

At a glance

Generic nameBioactive glass
Also known asSylc, Novabone
SponsorKing Abdulaziz University
Drug classBioactive ceramic material
ModalitySmall molecule
Therapeutic areaOrthopedics / Regenerative Medicine
PhasePhase 3

Mechanism of action

Bioactive glass is a silica-based ceramic material that forms a chemical bond with bone tissue through a series of surface reactions. When implanted, it releases calcium, phosphate, and silica ions that create an apatite layer on the glass surface, which mimics the mineral phase of bone and promotes new bone formation. This material also exhibits antimicrobial properties and can modulate inflammatory responses to support tissue regeneration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: